SoundHound AI Partners with MUSC Health to Enhance Patient Access with AI
SoundHound AI, Inc. (Nasdaq: SOUN), a leader in voice artificial intelligence, announced that MUSC Health has launched an AI agent named Emily, powered by the Amelia Patient Engagement solution, to…
Delcath Systems Reports Positive Study Results on Liver Therapy for Uveal Melanoma
Delcath Systems, Inc. (Nasdaq: DCTH), a company specializing in interventional oncology for treating liver cancers, announced the publication of a clinical study in the journal Therapeutic Advances in Medical Oncology.…
PatientPay and ClearGage Merge to Transform Healthcare Billing
PatientPay, a top provider of patient billing and payments for acute, ambulatory, and specialty care, and ClearGage, known for its healthcare estimate and payment solutions, have completed their merger. The…
Fresenius Kabi Adds Generic Reproductive Health Option
Fresenius Kabi has introduced Cetrorelix Acetate for Injection, an FDA-approved, cost-effective generic option for women’s reproductive health. The kit, available immediately, includes one single-dose vial of 0.25 mg cetrorelix, a…
UptimeHealth Announces Dental Fix Summit 2024 for Technicians
UptimeHealth, in partnership with the College of Biomedical Equipment Technology (CBET), is pleased to announce the Dental Fix Summit 2024. The event will be held from October 3-6, 2024, at…
Pfizer Unveils PfizerForAll™ Digital Health Platform
Pfizer Inc. has launched PfizerForAll, a user-friendly digital platform designed to streamline healthcare access and management for Americans. The platform simplifies the process for individuals and families to take important…
Navigator Medicines Announces $100M for NAV-240 Autoimmune Therapy
Navigator Medicines, a biotech company focused on advancing biologics for immune regulation, announced a $100 million Series A financing and the in-licensing of NAV-240 and an OX40L-targeted portfolio from IMBiologics…
McKesson to Acquire Majority Stake in Florida Cancer Specialists & Research Institute’s Core Ventures
McKesson Corporation (NYSE: MCK) has announced a definitive agreement to acquire a controlling interest in Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures) for approximately $2.49 billion in cash, representing…
Omnipod® 5 System FDA-Cleared for Type 2 Diabetes
Insulet Corporation (NASDAQ: PODD), a leader in tubeless insulin pump technology with its Omnipod® brand, has announced that its Omnipod 5 Automated Insulin Delivery System is now FDA-cleared for adults…
Gossamer Bio to Present Data at ERS Congress 2024
Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company dedicated to developing and commercializing seralutinib for pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), has…
Dr. Juliana Blum Appointed CEO of BioAesthetics
BioAesthetics Corporation has appointed Dr. Juliana Blum, PhD, as its new Chief Executive Officer, starting August 12, 2024. Dr. Sandra Coufal, MD, Director of BioAesthetics and CEO of Toragen, Inc.,…
Reliance Rx Teams Up with Waltz Health to Cut Specialty Medication Costs
Waltz Health, a digital health firm specializing in innovative medication pricing and distribution solutions, has partnered with specialty pharmacy leader Reliance Rx to reduce prescription specialty drug costs. As part…